Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability Comparison of Fluorometholone Acetate Ophthalmic Suspension 0.1% (Flarex) to Loteprednol Etabonate Ophthalmic Gel 0.38% (Lotemax SM)

NCT07588074 is registered in ClinicalTrials.gov with Harrow Inc as lead sponsor.

NCT NCT07588074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07588074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability Comparison of Fluorometholone Acetate Ophthalmic Suspension 0.1% (Flarex) to Loteprednol Etabonate Ophthalmic Gel 0.38% (Lotemax SM)
Lead sponsor
Harrow Inc
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2021
Completion date
June 30, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded), dry eye syndromes, kerato conjunctivitis sicca, keratoconjunctivitis, ocular inflammation, post-operative complications, postoperative complications